Professor Per Hammarstrom and a team of associate scientists from the Linkoping University in Sweden recently developed a molecular probe capable of detecting various amyloid deposits in human tissues. There are approximately 30 different types of amyloid proteins that are normally found throughout the body. However, under certain circumstances, these proteins break apart, fold abnormally and clump together, which leads to various disease processes capable of affecting any organ in the body. The probe increases the likelihood of early detection and treatment of amyloidosis. Here’s what Alzheimer’s caregivers in Ft. Lauderdale need to know about this revolutionary discovery. After creating the probe, scientists tested the technique to determine if the device might positively identify the amyloid proteins in various samples. The probe successfully identified the compounds and proved to be more accurate and efficient compared to previously designed clinical tests. The innovative testing method detected proteins that traditional methods failed to find. Up until the Linkoping researchers developed the probe, previous testing required staining blood, urine or tissue samples with Congo red and analyzing the slides using polarized light or electron microscopy. However, if samples do not contain sufficient quantities of the proteins, test results might prove falsely negative. However, this is no longer a concern when using the new probe. The group of scientists believes that the sensitivity of the probe makes an outstanding alternative to traditional testing methods and may eventually make the older technique obsolete. The U.S. Office of Rare Diseases explains that amyloidosis is a rare disease that is diagnosed in fewer than 200,000 people. However, according to the Amyloidosis Foundation, more people may actually suffer from medical conditions caused by the proteins than previously known. Once the non-invasive probe testing becomes more widely available, laboratories could identify the proteins as causative factors faster. Seniors who might otherwise require Ft. Lauderdale dementia home care would then receive treatments based on the presence of the proteins before they permanently cause substantial tissue damage. The presence of amyloidosis indicates that seniors are likely to develop dementia and Alzheimer’s. To help your loved one manage Alzheimer’s and dementia symptoms in the familiarity of home, turn to Home Care Assistance of Ft. Lauderdale. In addition to helping seniors with personal care and mobility assistance, we supplement our Alzheimer’s services with our proprietary Cognitive Therapeutics Method to sharpen mental acuity and delay the onset of dementia symptoms. Learn more when you call (954) 909-0370 and schedule a complimentary consultation.